Already have a subscription?Sign In
Log in to see the full chart
Log in or register for a free account to get full, unrestricted access to this chart
Log in to see the full chart
August 17, 2021
Industry Trends that Are Expected to Have the Greatest Impact on the Biopharmaceutical Industry in 2021 According to Pharmaceutical Executives Worldwide, Dec 2020 (% of respondents)
Methodology
Data is from an August 2021 GlobalData report titled "The State of the Biopharmaceutical Industry- 2021" as cited in company blog. 198 pharmaceutical executives worldwide at GlobalData clients and prospects were surveyed during November 17-December 11, 2020. The respondents are from approximately 30 countries in North America (n=89), Europe (n=64), Asia-Pacific (n=25), and other parts of the world (n=20). The majority of the respondents from the North America region were coming from the US. The respondents were C-level executives (13%), VP/SVP/EVPs (20%), directors (31%), managers (23%), and associate/nonmanagerial positions (13%). Respondent mix by company size constitutes less than 500 employees (54%), 500-999 employees (10%), 1,000-4,999 employees (14%), 5,000-9,999 employees (7%), and 10,000+ employees (17%).Chart Title
Industry Trends that Are Expected to Have the Greatest Impact on the Biopharmaceutical Industry in 2021 According to Pharmaceutical Executives Worldwide, Dec 2020 (% of respondents)Publication Date
August 17, 2021